Peter Wenaweser

Interventional cardiologist / Cardiologist
Cardiovascular Center Zurich, Hirslanden Klinik im Park - Zurich, Switzerland

Latest contributions

The Netherlands and Switzerland share their most educational cases: complications in TAVI

18 May 2017 – From EuroPCR 2017

PCR's Got Talent - Round 2 - Session 1

18 May 2017 – From EuroPCR 2017

Bioprosthetic valve leaflet thickening and long-term durability

16 May 2017 – From EuroPCR 2017

Consult this session on bioprosthetic valve leaflet thickening and long-term durability from EuroPCR 2017 if you want to find more about mechanisms of bioprosthetic valve failure and definitions of valve durability and clinical data concerning the long-term outcomes after TAVI.

Patient outcome following mitral valve repair or replacement

16 May 2017 – From EuroPCR 2017

LIVE case: TF TAVI with Evolut R in a suitable patient

From EUROPCR 2016

"Extract from a session sponsored by MEDTRONIC."

Watch this LIVE case if you want to learn more about TF TAVI with Evolut R in a suitable patient.

A 80-year-old female with severe aortic stenosis:

Intermediate riskSimplified approachWithout predilatation
Prof. Stefan Windecker

Operator

Stephan Windecker

Operator

Peter Wenaweser

Transcatheter aortic valve-in-valve implantation

17 May 2016 – From EuroPCR 2016

Thomas Modine

Chairperson

Thomas Modine
Carlos E. Ruiz

Chairperson

Carlos E. Ruiz

Measures to minimise paravalvar aortic regurgitation post-TAVI

20 May 2015 – From EuroPCR 2015

How to optimise outcomes: access management when using large-size sheaths

20 May 2015 – From EuroPCR 2015

Watch this session video from EuroPCR 2015 on how to optimise outcomes: access management when using large-size sheaths.

Geneva University Hospital

Chairperson

Marco Roffi

Percutaneous aortic valve interventions in heart failure patients

19 May 2015 – From EuroPCR 2015

Dr. Alec Vahanian

Chairperson

Alec Vahanian

TAVI: how to prevent thromboembolic complications?

19 May 2015 – From EuroPCR 2015

Coronary revascularisation and TAVI: before, during, after or never?

21 May 2014 – From EuroPCR 2014

Corrado Tamburino

Chairperson

Corrado Tamburino
Hendrik Treede

Chairperson

Hendrik Treede

The Medtronic transcatheter valve programmes - Recapturability, transapical technology and mitral solutions

22 May 2013 – From EuroPCR 2013

Chairperson

Daniel Blackman
Axel Linke

Chairperson

Axel Linke

Conduction disturbances after TAVI

22 May 2013 – From EuroPCR 2013

Dr. Nicolo Piazza

Chairperson

Nicolo Piazza

Chairperson

Peter Wenaweser

Percutaneous mitral valve repair with the MitraClip system: determinants of outcome

22 May 2013 – From EuroPCR 2013

Francesco Maisano

Chairperson

Francesco Maisano

Chairperson

Peter Wenaweser

TAVI results from worldwide registries

21 May 2013 – From EuroPCR 2013

Prof. Alain Cribier

Chairperson

Alain Cribier
Prof. Junbo Ge

Chairperson

Junbo Ge

The most relevant clinical trials

25 Jan 2013 – From AsiaPCR/SingLIVE 2013

Dr. Christoph K. Naber

Chairperson

Christoph K. Naber
Jun-Jack Cheng

Chairperson

Jun-Jack Cheng

LIVE demonstration from the National Heart Centre Singapore

24 Jan 2013 – From AsiaPCR/SingLIVE 2013

Eberhard Grube

Chairperson

Eberhard Grube

Chairperson

Peter Wenaweser

Structural heart

24 Jan 2013 – From AsiaPCR/SingLIVE 2013

Chairperson

Maurice Choo

Chairperson

Peter Wenaweser